Rapid recruitment in emerging regions can overload sites; FDA

By Nick Taylor

- Last updated on GMT

Related tags: Food and drug administration, Fda

The US FDA has warned that rapid patient enrolment in emerging markets can overload sites that lack the staff to oversee data as it is generated.

Sponsors are conducting clinical trials oversees to benefit from faster patient recruitment but should be careful what they wish for, a medical officer at the US Food and Drug Administration (FDA) warns.

In certain regions you’re going to see more subjects per site [and] you have to be prepared for that rapid enrolment​”, Cynthia Kleppinger, medical officer, division of scientific investigations, at the FDA told Outsourcing-Pharma.

Clinical trial sites lacking the resources to handle large numbers of patients can be overwhelmed. Other emerging market problems discussed by Kleppinger include lack of infrastructure, such as the investigator that went without safety data for a month because the fax machine was broken.

Issues raised by Kleppinger will be among the topics discussed by leaders from Merck & Co, Novartis, Roche and more at an Outsourcing-Pharma conference next month. The event, Patient Recruitment Outsourcing, takes place in Boston, Massachusetts on September 26 and 27.

To find out more and sign up for the event click here​.

Related news

Show more

Related products

show more

Strategic Approach to Immunogenicity Assessment

Strategic Approach to Immunogenicity Assessment

Altasciences | 17-May-2022 | Technical / White Paper

In this issue of The Altascientist we provide a detailed overview on the different goals and challenges that are presented by the validation of immunogenicity...

Governing and Maintaining Clinical Data Standards

Governing and Maintaining Clinical Data Standards

Veeva | 10-May-2022 | Technical / White Paper

Investing in data standards plays a huge role in improving the quality of clinical studies. But often, people don’t use the standards correctly, there...

What the Best Clinical Study Build Pros Do

What the Best Clinical Study Build Pros Do

Formedix | 09-May-2022 | Technical / White Paper

Getting your clinical study designed and built ready for data collection takes A LOT of work and expertise… you've got to do all your CRF designs;...

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 18-Apr-2022 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Related suppliers

Follow us


View more